GENE ID: ENSDARG00000068507


Symbol Location Gene type Genome version Species
crybb1 10: 44021147 ~ 44027391 (-) protein_coding GRCz11 Danio rerio

  • PPI (protein-protein interaction) results are shown above.
  • Green is ENSDARG00000068507 (crybb1), yellow represents other genes.
  • Hover over the node can see the symbol/gene ID it represents.
  • The more connections, the bigger symbol size.


  • MARKER



    EXPRESSION


    Dataset ID Tissue / Organ Experiment type Sample Cell type Marker class Evidence
    PRJNA564810 (5dpf) embryo baseline 5dpf, a single-cell transcriptome atlas for zebrafish development Lens (cluster: 25)
    marker
    DOI:10.1093/g3journal/jkac062
    GSE158142 (5dpf) brain, eye baseline 5dpf, untreatment
    PRJNA564810 (2dpf) embryo baseline 2dpf, a single-cell transcriptome atlas for zebrafish development Lens (cluster: 23)
    potential marker
    NA
    PRJNA564810 (1dpf) embryo baseline 1dpf, a single-cell transcriptome atlas for zebrafish development Lens (cluster: 29)
    potential marker
    NA
    GSE122680 (24hpf) retina baseline 24hpf, WT, untreatment Horizontal cells (cluster: 4)
    potential marker
    NA
    GSE122680 (14dpf) retina baseline 14dpf, WT, untreatment
    GSE158099 (runx1 -|-) whole body hematopoietic 16dpf, cd41:GFPlow-runx1-/- Epidermal cells (cluster: 13)
    potential marker
    NA
    GSE158142 (8dpf) brain, eye baseline 8dpf, untreatment
    GSE144944 (fgfr3 -|-) cranial vault growth 1mpf, fgfr3 -/-
    GSE144944 (fgfr3 +|+) cranial vault baseline 1mpf, fgfr3 +/+
    GSE173972 (HET, ezh1+|-) embryo hematopoietic 1.25dpf, Kdrl-positive embryos
    PRJNA734348 (shield, dnmt1) embryo growth 6hpf, shield, oocyte microinjection with Rhodamine B and dnmt1 MO at oogenesis III stage (GV)
    GSE158849 (unlabeled) embryo baseline 6hpf, WT, 4sUTP injected (unlabeled)
    GSE173972 (KO, ezh1-|-) embryo hematopoietic 1.25dpf, Kdrl-positive embryos
    PRJNA734348 (dome, dnmt1) embryo growth 4.3hpf, dome, oocyte microinjection with Rhodamine B and dnmt1 MO at oogenesis III stage (GV)
    GSE126647 (control) embryo baseline 1.17dpf, control nkx2.5:ZsYellow+ cells
    GSE106587 (WT) embryo baseline 12hpf, 6 somites, wild-type TLAB embryo
    PRJNA734348 (shield, control) embryo baseline 6hpf, shield, oocyte microinjection with Rhodamine B and control MO at oogenesis III stage (GV)
    GSE158142 (16hpf) head baseline 16hpf, 14 somites, untreatment
    GSE158142 (1.5dpf) head baseline 1.5dpf, untreatment
    GSE158142 (18hpf) head baseline 18hpf, 18 somites, untreatment
    GSE158142 (2dpf) head baseline 2dpf, untreatment
    GSE158142 (20hpf) head baseline 20hpf, 21-22 somites, untreatment
    GSE158142 (3dpf) head baseline 3dpf, untreatment
    GSE158142 (24hpf) head baseline 24hpf, untreatment
    GSE158142 (14hpf) head baseline 14hpf, 10 somites, untreatment
    PRJNA608912 (wt_2dpi) heart regeneration 5mpf, wild type, 2 days post injury
    PRJNA668529 (3d) olfactory rosette disease 3mpf, intranasal 100ng r-Spike 3 days
    GSE122680 (2dpf) retina baseline 2dpf, WT, untreatment
    GSE122680 (1.5dpf) retina baseline 1.5dpf, WT, untreatment
    GSE122680 (3dpf) retina baseline 3dpf, WT, untreatment
    GSE152982 (wild type) trunk baseline 1.25dpf, untreatment
    GSE131136 (all) trunk, skin baseline 5dpf, sox10:CRE positive cells from 5dpf and post-embryonic zebrafish trunks with and without thyroid hormone
    GSE159709 (melanoma) tumor disease adult, equal numbers of sorted GFP+ (tumor) and GFP- (macroenvironment) cells
    GSE158099 (WT) whole body baseline 16dpf, cd41:GFPlow-WT
    GSE158099 (runx1 -|-) whole body hematopoietic 16dpf, cd41:GFPlow-runx1-/-
    GSE158099 (runx1 -|-) whole body hematopoietic 2.5dpf, cd41:GFPlow-runx1-/-
    GSE158099 (WT) whole body baseline 2.5dpf, cd41:GFPlow-WT
    GSE158099 (runx1 -|-) whole body hematopoietic 10dpf, cd41:GFPlow-runx1-/-
    GSE176129 (pdgfrb-positive) whole body baseline 5dpf, FACS-isolated pdgfrb-positive cells

        After clicking the magnifying glass button, the clustering and expression information will be displayed below.